Caspase Inhibitor Z-Vad-fmk Increases the Survival of Hair Cells after Actinomycin-D-induced Damage in Vitro

Huimin Chang,Fei Sun,Keyong Tian,Weilong Wang,Ke Zhou,Dingjun Zha,Jianhua Qiu
DOI: https://doi.org/10.1016/j.neulet.2020.135089
IF: 3.197
2020-01-01
Neuroscience Letters
Abstract:Actinomycin-D (Act-D) is a highly effective chemotherapeutic agent that induces apoptosis in systemic tissues. Act-D combined with other chemotherapeutic agents exhibits ototoxic effects and causes hearing impairment. To investigate the potential toxic effects of Act-D in the inner ear, we treated cochlear organotypic cultures with varying concentrations of Act-D for different durations. For the first time, we found that Act-D specifically induced HC loss and apoptosis in a dose- and time-dependent manner but not neuronal degeneration. Cotreatment with benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (z-VAD-FMK), a pan cysteine protease inhibitor, significantly reduced HC loss and apoptosis induced by Act-D, indicating increased cell survival. Taken together, Act-D exposure has ototoxic effects on the auditory system, while z-VAD-FMK prevents Act-D-induced hair cell damage.
What problem does this paper attempt to address?